182 related articles for article (PubMed ID: 24184416)
1. Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
Du-Thanh A; Girard C; Pageaux GP; Guillot B; Dereure O
Eur J Dermatol; 2013; 23(6):900-1. PubMed ID: 24184416
[No Abstract] [Full Text] [Related]
2. Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
İlknur T; Akarsu S; Çarsanbali S; Lebe B; Fetil E
J Drugs Dermatol; 2014 Aug; 13(8):899-900. PubMed ID: 25116964
[No Abstract] [Full Text] [Related]
3. Grade III hand-foot skin reaction induced by sorafenib.
Chiriac A; Coros MF; Podoleanu C; Stolnicu S
An Bras Dermatol; 2017; 92(4):590-591. PubMed ID: 28954127
[No Abstract] [Full Text] [Related]
4. A case of reversible cardiomyopathy associated with sorafenib in advanced hepatocellular carcinoma.
Park H; Han SH; Kang H; Park K
Int J Cardiol; 2012 Sep; 160(1):e10-1. PubMed ID: 22289299
[No Abstract] [Full Text] [Related]
5. Small-intestinal hemorrhage caused by treatment with sorafenib for hepatocellular carcinoma and diagnosed by capsule endoscopy.
Takahashi Y; Fukunishi S; Nishikawa T; Nouda S; Sasaki Y; Sanomura M; Umegaki E; Higuchi K
Endoscopy; 2013; 45 Suppl 2 UCTN():E179-80. PubMed ID: 23801291
[No Abstract] [Full Text] [Related]
6. Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib.
Coppola R; Zanframundo S; Rinati MV; Carbotti M; Graziano A; Galati G; De Florio L; Panasiti V
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1028-9. PubMed ID: 24628665
[No Abstract] [Full Text] [Related]
7. Paradoxical exacerbation of chronic plaque psoriasis by sorafenib.
Yiu ZZ; Ali FR; Griffiths CE
Clin Exp Dermatol; 2016 Jun; 41(4):407-9. PubMed ID: 26667599
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: could we stop the treatment? About four cases.
Poullenot F; Bioulac-Sage P; Laumonier H; Saric J; Carteret T; Blanc JF
Acta Oncol; 2014 Mar; 53(3):420-3. PubMed ID: 23713857
[No Abstract] [Full Text] [Related]
9. Spontaneous deep venous thrombosis: An unrecognized entity with sorafenib.
Madabhavi I; Patel A; Anand A; Choudhary M; Revannasiddaiah S
J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881607
[TBL] [Abstract][Full Text] [Related]
10. Abdominal Distension in a Patient With Hepatocellular Carcinoma. Benign Pneumatosis Intestinalis and Pneumoperitoneum Associated With Sorafenib Therapy.
Huang YH; Siao FY; Yen HH
Gastroenterology; 2015 Aug; 149(2):e12-3. PubMed ID: 26123559
[No Abstract] [Full Text] [Related]
11. Tolerability of single-agent sorafenib in the treatment of elderly patients with hepatocellular carcinoma (HCC).
Francini E; Bianco V
Hepatology; 2014 Aug; 60(2):764-5. PubMed ID: 25187926
[No Abstract] [Full Text] [Related]
12. Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma.
Tajiri K; Nakajima T; Kawai K; Minemura M; Sugiyama T
Intern Med; 2015; 54(6):597-600. PubMed ID: 25786448
[TBL] [Abstract][Full Text] [Related]
13. [Current status and future perspective of sorafenib for advanced hepatocellular carcinoma].
Ikeda M; Mitsunaga S; Shimizu S; Ohno I; Takahashi H; Okuyama H; Kuwahara A; Okusaka T
Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1346-54. PubMed ID: 22863957
[No Abstract] [Full Text] [Related]
14. [Metastatic adrenal necrosis under sorafenib treatment for hepatocellular carcinoma].
Fabries P; Pauleau G; Brardjanian S; Artéaga C; Guisset M; Coton T
Presse Med; 2013 Feb; 42(2):235-7. PubMed ID: 22425476
[No Abstract] [Full Text] [Related]
15. Delayed onset perforating folliculitis associated with sorafenib.
Batalla A; Menéndez L; Blay P; Curto JR
Australas J Dermatol; 2014 Aug; 55(3):233-5. PubMed ID: 25117168
[No Abstract] [Full Text] [Related]
16. Perforating folliculitis-like reaction related to sorafenib.
Eberst E; Rigau V; Pageaux GP; Guillot B; Kluger N
Cutis; 2014 Jan; 93(1):E8-10. PubMed ID: 24505595
[No Abstract] [Full Text] [Related]
17. Painful Rashes on the Palms and Soles.
Bhullar M; Bhullar A; Arachchi NJ
Ann Acad Med Singap; 2016 Oct; 45(10):479-480. PubMed ID: 27832225
[No Abstract] [Full Text] [Related]
18. Sorafenib-induced psoriasis and hand-foot skin reaction responded dramatically to systemic narrowband ultraviolet B phototherapy.
Hung CT; Chiang CP; Wu BY
J Dermatol; 2012 Dec; 39(12):1076-7. PubMed ID: 22724918
[No Abstract] [Full Text] [Related]
19. Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients.
Mancuso A; Zavaglia C; Bai F; Puoti M; Belli LS
Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1414-6. PubMed ID: 24206381
[No Abstract] [Full Text] [Related]
20. Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma.
Grieco A; Lombardo A; Biolato M
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):1001-2. PubMed ID: 23817448
[No Abstract] [Full Text] [Related]
[Next] [New Search]